Sugi Predict

Sugi Predict / Compounds / SCHEMBL1702508

SCHEMBL1702508

SCHEMBL1702508

CCCCCCCCCCCC(C=C(C)C(=O)O)C=C(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.50
▸ PPARD Q03181 1/20 0.50
▸ ZDHHC20 Q5W0Z9 1/20 0.50
▸ ZDHHC2 Q9UIJ5 1/20 0.50
▸ GPR84 Q9NQS5 7/20 0.47
▸ FFAR1 O14842 2/20 0.47
▸ MAPT P10636 1/20 0.46
▸ FFAR4 Q5NUL3 1/20 0.43
▸ ACE2 Q9BYF1 1/20 0.43
▸ ZDHHC7 Q9NXF8 1/20 0.42
▸ EP300 Q09472 1/20 0.41
▸ FAAH O00519 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ FNTA P49354 1/20 0.40
▸ FNTB P49356 1/20 0.40
▸ PGGT1B P53609 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2350390 1.00 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL6472685 0.92 CA2 (0.42) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL26624434 0.85 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL18173540 0.85 LCK (0.55) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL11659422 0.85 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL27513963 0.85 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL11024665 0.85 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL11661583 0.85 LCK (0.50) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL1702463 0.84 CHRM1 (0.41) LCKPPARDZDHHC20ZDHHC2GPR84
SCHEMBL10386188 0.83 LCK (0.48) LCKPPARDZDHHC20ZDHHC2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113454147-A Crosslinkable electroactive fluorinated polymers comprising photoactive groups 阿科玛法国公司 2021-09-28 — — CN claimed
CN-113423740-A Crosslinkable electroactive fluorinated polymers comprising photoactive groups 阿科玛法国公司 2021-09-21 — — CN claimed
EP-1925043-B1 ENCAPSULATED DEVICES AND METHOD OF MAKING SAMSUNG MOBILE DISPLAY CO LTD (KR) 2011-05-11 — — EP claimed
CN-113454147-B Crosslinkable electroactive fluorinated polymers comprising photoactive groups 阿科玛法国公司 2024-05-10 — — CN disclosed
CN-110506063-B Crosslinkable compositions based on electroactive fluorinated copolymers 阿科玛法国公司 2023-09-29 — — CN disclosed
US-11179299-B2 System and method for applying oral care agents KONINKLIJKE PHILIPS N.V. (NL) 2021-11-23 — — US disclosed
CN-113454147-A Crosslinkable electroactive fluorinated polymers comprising photoactive groups 阿科玛法国公司 2021-09-28 — — CN disclosed
CN-113423740-A Crosslinkable electroactive fluorinated polymers comprising photoactive groups 阿科玛法国公司 2021-09-21 — — CN disclosed
EP-3068367-B1 SYSTEM AND METHOD FOR APPLYING ORAL CARE AGENTS KONINKLIJKE PHILIPS NV (NL) 2020-06-17 — — EP disclosed
US-20160296427-A1 SYSTEM AND METHOD FOR APPLYING ORAL CARE AGENTS KONINKLIJKE PHILIPS N.V. (NL) 2016-10-13 — — US disclosed
EP-3068367-A1 SYSTEM AND METHOD FOR APPLYING ORAL CARE AGENTS Koninklijke Philips N.V. (NL) 2016-09-21 — — EP disclosed
US-7241856-B2 Dental resins, dental composite materials, and method of manufacture thereof PENTRON CLINICAL TECHNOLOGIES LLC (US) 2007-07-10 — — US disclosed
US-20070122361-A1 Tooth colorant and whitener, method of manufacture, and method of use thereof PENTRON CLINICAL TECHNOLOGIES LLC 2007-05-31 — — US disclosed
US-20060241205-A1 Filler materials for dental composites PENTRON CLINICAL TECHNOLOGIES, LLC 2006-10-26 — — US disclosed
US-20060111465-A1 Dental glazes and method of manufacture and use thereof PENTRON CORPORATION 2006-05-25 — — US disclosed
US-20060009540-A1 Dental resins, dental composite materials, and method of manufacture thereof PENTRON CORPORATION 2006-01-12 — — US disclosed
US-20040242723-A1 Dental resins, dental composite materials, and method of manufacture thereof PENTRON CORPORATION 2004-12-02 — — US disclosed
US-6787629-B2 POLYCARBONATE-MODIFIED DIPHENOXY DIACRYLATE; WEAR RESISTANCE PENTRON CLINICAL TECHNOLOGIES, LLC 2004-09-07 — — US disclosed
US-20040086446-A1 Dental resin materials, method of manufacture, and uses thereof PENTRON CORPORATION 2004-05-06 — — US disclosed
US-20030125444-A1 Dental resin materials, method of manufacture, and uses thereof PENTRON CORPORATION 2003-07-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111465-A1 Dental glazes and method of manufacture and use thereof GLA, RARG, ECPAS LCK 4320/4885PPARD 696/4885ZDHHC20 1713/4885
US-11179299-B2 System and method for applying oral care agents OLA1, OTC, LPO LCK 4321/4885PPARD 4149/4885ZDHHC20 2769/4885
US-20160296427-A1 SYSTEM AND METHOD FOR APPLYING ORAL CARE AGENTS OLA1, OTC, LPO LCK 4321/4885PPARD 4149/4885ZDHHC20 2769/4885
US-20060009540-A1 Dental resins, dental composite materials, and method of manufacture thereof MMAB, SMCHD1, CAD LCK 4833/4885PPARD 3663/4885ZDHHC20 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.